In another study comparing patients with HCC managed by a multidisciplinary tumor board (MDTB) to those who were not, it was demonstrated that patients managed by MDTB were more likely to present with cancer at earlier stages and with lower serum alpha-fetoprotein (AFP). Here, AFP is linked to cancer.